JP2002526410A5 - - Google Patents

Download PDF

Info

Publication number
JP2002526410A5
JP2002526410A5 JP2000573362A JP2000573362A JP2002526410A5 JP 2002526410 A5 JP2002526410 A5 JP 2002526410A5 JP 2000573362 A JP2000573362 A JP 2000573362A JP 2000573362 A JP2000573362 A JP 2000573362A JP 2002526410 A5 JP2002526410 A5 JP 2002526410A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylcarbamoyl
cyano
hydrogen
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000573362A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002526410A (ja
Filing date
Publication date
Priority claimed from GBGB9821703.7A external-priority patent/GB9821703D0/en
Priority claimed from GBGB9905238.3A external-priority patent/GB9905238D0/en
Application filed filed Critical
Priority claimed from PCT/GB1999/003273 external-priority patent/WO2000020003A1/en
Publication of JP2002526410A publication Critical patent/JP2002526410A/ja
Publication of JP2002526410A5 publication Critical patent/JP2002526410A5/ja
Pending legal-status Critical Current

Links

JP2000573362A 1998-10-07 1999-10-04 タキキニン受容体拮抗剤としてのナフタレンカルボキシアミド Pending JP2002526410A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9821703.7 1998-10-07
GBGB9821703.7A GB9821703D0 (en) 1998-10-07 1998-10-07 Compounds
GB9905238.3 1999-03-09
GBGB9905238.3A GB9905238D0 (en) 1999-03-09 1999-03-09 Compounds
PCT/GB1999/003273 WO2000020003A1 (en) 1998-10-07 1999-10-04 Naphthalenecarboxamides as tachykinin receptor antagonists

Publications (2)

Publication Number Publication Date
JP2002526410A JP2002526410A (ja) 2002-08-20
JP2002526410A5 true JP2002526410A5 (enExample) 2006-11-24

Family

ID=26314462

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000573362A Pending JP2002526410A (ja) 1998-10-07 1999-10-04 タキキニン受容体拮抗剤としてのナフタレンカルボキシアミド

Country Status (15)

Country Link
US (1) US6500818B1 (enExample)
EP (1) EP1119355B1 (enExample)
JP (1) JP2002526410A (enExample)
KR (1) KR20010099674A (enExample)
CN (1) CN1322134A (enExample)
AT (1) ATE230598T1 (enExample)
AU (1) AU6111099A (enExample)
BR (1) BR9914333A (enExample)
CA (1) CA2344807A1 (enExample)
DE (1) DE69904847T2 (enExample)
GB (1) GB9922519D0 (enExample)
ID (1) ID25749A (enExample)
IL (1) IL142048A0 (enExample)
NO (1) NO20011766L (enExample)
WO (1) WO2000020003A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2307605T3 (es) * 2000-04-06 2008-12-01 Astrazeneca Ab Nuevos antagonistas de neuroquininas para su uso como medicamentos.
ATE308513T1 (de) * 2000-04-06 2005-11-15 Naphthamid-neurokinin antagonisten zur verwendung als medikamente
US6903092B2 (en) 2000-04-06 2005-06-07 Peter Bernstein Naphthamide neurokinin antagonists for use as medicaments
US6846814B2 (en) 2000-04-06 2005-01-25 Astra Zeneca Ab Neurokinin antagonists for use as medicaments
GB0015246D0 (en) * 2000-06-22 2000-08-16 Astrazeneca Ab Method for the treatment of urinary incontinence
SE0004827D0 (sv) 2000-12-22 2000-12-22 Astrazeneca Ab Therapeutic compounds
SE0103668D0 (sv) * 2001-11-02 2001-11-02 Astrazeneca Ab Method for the treatment of overactive blader
SE0103795D0 (sv) 2001-11-02 2001-11-02 Astrazeneca Ab Compounds and method for the treatment of överactive bladder
SE0201938D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New process
FR2853648B1 (fr) * 2003-04-11 2006-08-18 Fournier Lab Sa Nouveaux derives de benzenesulfonamides et leur utilisation en therapeutique
TW200508221A (en) * 2003-06-13 2005-03-01 Astrazeneca Ab New azetidine compounds
SE0403005D0 (sv) * 2004-12-09 2004-12-09 Astrazeneca Ab New use
CN101203511A (zh) * 2005-06-23 2008-06-18 阿斯利康(瑞典)有限公司 作为神经激肽受体拮抗剂用于治疗胃肠疾病的新氮杂环丁烷衍生物
CN101208327A (zh) * 2005-06-23 2008-06-25 阿斯利康(瑞典)有限公司 作为神经激肽受体拮抗剂用于治疗胃肠疾病的新氮杂环丁烷衍生物
AR056087A1 (es) * 2005-09-29 2007-09-19 Astrazeneca Ab Derivados de azetidina como antagonistas de receptores de neuroquina nk
AR057828A1 (es) * 2005-09-29 2007-12-19 Astrazeneca Ab Compuestos derivados de azetidina, su preparacion y composicion farmaceuutica
CN101374811A (zh) * 2006-02-01 2009-02-25 索尔瓦药物有限公司 新型双重nk2/nk3-拮抗剂、含它们的药物组合物、及其制备方法
US8106208B2 (en) 2006-05-18 2012-01-31 Albireo Ab Benzamide compounds that act as NK receptor antagonists
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
CA2740970A1 (en) 2008-10-21 2010-04-29 Oregon Health & Science University Naphthamides as anticancer agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI97540C (fi) 1989-11-06 1997-01-10 Sanofi Sa Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
IL99320A (en) 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical compositions containing them
FR2676054B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
GB9310713D0 (en) * 1993-05-24 1993-07-07 Zeneca Ltd Aryl substituted heterocycles

Similar Documents

Publication Publication Date Title
CN1134417C (zh) 3-苯基吡啶衍生物及其作为nk-1受体拮抗剂的应用
TWI658836B (zh) 治療肺部疾病的高穿透力前藥組合物、其醫藥組合物及其用途
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
JP2000159749A5 (enExample)
TW200628472A (en) Piperidinylamino-thieno (2,3-d) pyrimidine compounds
HRP20110781T1 (hr) Derivati azabiciklo[3.1.0]heksana, korisni kao modulatori dopaminskih receptora d3
EP2592070A3 (en) Tetrazole-substituted arylamides
JP2009523760A5 (enExample)
JP2004520324A5 (enExample)
US20130123291A1 (en) Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors
TW200716520A (en) 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
JP2004507527A5 (enExample)
JP2009538873A5 (enExample)
JP2007520440A5 (enExample)
CA2428039A1 (en) Serotonergic agents
JP2004517130A5 (enExample)
JP2005527542A5 (enExample)
JP2005521651A5 (enExample)
JP2004509954A5 (enExample)
JP2002526527A5 (enExample)
JP2002531548A5 (enExample)
CN1615309A (zh) 用作磷酸二酯酶抑制剂的被取代的四环吡咯并喹诺酮衍生物
JP2004510813A5 (enExample)
JP2004504308A5 (enExample)
CN106715395B (zh) 作为taar调节剂的6-氨基-5,6,7,8-四氢萘-2-基或3-氨基色满-7-基衍生物